AU2001289719A1 - Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain - Google Patents

Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain

Info

Publication number
AU2001289719A1
AU2001289719A1 AU2001289719A AU8971901A AU2001289719A1 AU 2001289719 A1 AU2001289719 A1 AU 2001289719A1 AU 2001289719 A AU2001289719 A AU 2001289719A AU 8971901 A AU8971901 A AU 8971901A AU 2001289719 A1 AU2001289719 A1 AU 2001289719A1
Authority
AU
Australia
Prior art keywords
preparation
treatment
pharmaceutical compositions
chronic pain
anellated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289719A
Inventor
Dietrich Arndts
Stefan Matthias Blech
Henning Draheim
Wolfram Gaida
Klaus Klinder
Walter Losel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Publication of AU2001289719A1 publication Critical patent/AU2001289719A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4747—Quinolines; Isoquinolines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
AU2001289719A 2000-07-25 2001-07-21 Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain Abandoned AU2001289719A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10035997A DE10035997A1 (en) 2000-07-25 2000-07-25 Use of fused dihydropyridines for the manufacture of agents for the treatment of chronic pain
DE10035997.3 2000-07-25
PCT/EP2001/008453 WO2002007714A2 (en) 2000-07-25 2001-07-21 Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain

Publications (1)

Publication Number Publication Date
AU2001289719A1 true AU2001289719A1 (en) 2002-02-05

Family

ID=7650021

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289719A Abandoned AU2001289719A1 (en) 2000-07-25 2001-07-21 Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain

Country Status (5)

Country Link
AR (1) AR029981A1 (en)
AU (1) AU2001289719A1 (en)
DE (1) DE10035997A1 (en)
UY (1) UY26852A1 (en)
WO (1) WO2002007714A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003014089A1 (en) * 2001-07-31 2003-02-20 Virginia Commonwealth University Aminotetrahydroisoquinoline derivatives as analgesics
RU2711646C1 (en) * 2019-04-08 2020-01-17 Федеральное государственное бюджетное учреждение науки Институт молекулярной генетики Российской академии наук Synthesis of tritium-labeled 6,7-dimethoxy-4,4-dimethyl-1-[4-(4-trifluoromethylphenoxy)phenyl]-3n-isoquinoline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386076A (en) * 1971-06-03 1975-03-05 Wyeth John & Brother Ltd Isoquinoline derivatives
PH25651A (en) * 1986-05-21 1991-08-21 Duphar Int Res New di, tetrahydroisoquinoline derivatives
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
BR9107169A (en) * 1990-12-17 1993-11-16 Shell Int Research FUNGICIDED ISOQUINOLINE DERIVATIVES
WO2000044725A1 (en) * 1999-01-28 2000-08-03 Boehringer Ingelheim Pharma Kg Fused dihydropyridines and use of fused dihydropyridines in the preparation of agents for the treatment of epilepsy

Also Published As

Publication number Publication date
WO2002007714A3 (en) 2002-09-06
DE10035997A1 (en) 2002-02-07
WO2002007714A2 (en) 2002-01-31
UY26852A1 (en) 2002-02-28
AR029981A1 (en) 2003-07-23

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
HUP0501089A2 (en) Therapeutic isoquinoline compounds and pharmaceutical compositions coutaining them
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
HUP0401642A3 (en) Use of staurosporine derivatives for the preparation of pharmaceutical compositions
AU2002313236A1 (en) Medicinal compositions
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2002258221A1 (en) Medicinal composition
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
IL161348A (en) Substituted 4- phenyl-4-[1h - imidazol-2-yl] piperidine derivatives and their use for the preparation of pharmaceutical compositions
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2002365093A1 (en) Therapeutic compositions
AUPR600601A0 (en) Therapeutic compositions
AU2002347360A1 (en) Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours
AU2002365665A1 (en) Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001289719A1 (en) Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain
AU2003236105A1 (en) Pharmaceutical composition for treatment of bph and preparation thereof
AU2002354460A1 (en) Medicinal composition
AUPR520701A0 (en) Herbal composition for the treatment of drug addiction
AU2683500A (en) Compositions for the treatment of pain
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
AU6106801A (en) Trans-clitoral administration of therapy
AU2002365863A1 (en) The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders